Immune reconstitution
Showing 1 - 25 of >10,000
Immune Reconstitution to CMV After HSCT: Impact of Clinical
Enrolling by invitation
- CMV Infection
- Hematopoietic Stem Cell Transplantation
-
Beijing, Beijing, China
- +1 more
Jan 5, 2023
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)
Recruiting
- Progressive Multifocal Leukoencephalopathy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 2, 2022
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,
Completed
- Kaposi Sarcoma
- +2 more
- Valganciclovir
- Antiretroviral Combinations
-
Mexico city, MexicoInstituto Nacional de Cancerologia
Nov 23, 2021
Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant
Recruiting
- Breast Carcinoma
- +2 more
- Recombinant human IL-7-hyFc (NT-I7)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Reconstitution ofHuman Immune System inPatient Derived Xenograft
Suspended
- Genito Urinary Cancer
- +3 more
- Bone marrow biopsy
- Tumor biopsy
-
Durham, North CarolinaDuke University Medical Center
Nov 17, 2022
Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)
Terminated
- Immunodeficiency
- Infusion of donor lymphocytes
-
Charlotte, North CarolinaLevine Children's Hospital, Carolinas Medical Center
Apr 20, 2022
Solid Tumor Malignancies Trial in Houston (Autologous lymphocyte infusion (ALI))
Recruiting
- Solid Tumor Malignancies
- Autologous lymphocyte infusion (ALI)
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
HIV Trial in Baltimore (Lopinavir/Ritonavir)
Terminated
- HIV
-
Baltimore, MarylandUniversity of Maryland, Institute of Human Virology
Jan 20, 2022
Pediatric Cancer Trial in Manchester (Granulocytes)
Recruiting
- Pediatric Cancer
- Granulocytes
-
Manchester, United KingdomRoyal Manchester Childrens Hospital, MFT
Jun 17, 2022
Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)
Recruiting
- Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
- Human T Lymphoid Progenitor (HTLP) injection
-
Pessac, France
- +1 more
Oct 28, 2021
HIV-1 Infection Trial in Toulouse (Peripheral blood and intestinal biopsies will be collected)
Completed
- HIV-1 Infection
- Peripheral blood and intestinal biopsies will be collected
-
Toulouse, France
- +1 more
Dec 30, 2021
Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)
Recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Personalized rATG (P-rATG)
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 31, 2022
Leukemia, Acute Trial in New York (Allogeneic T cell progenitors, cultured ex-vivo)
Recruiting
- Leukemia, Acute
- Allogeneic T cell progenitors, cultured ex-vivo
-
New York, New YorkMemorial Sloan Kettering Cancer Center (MSKCC)
Dec 9, 2021
Inflammation in HIV Infection Trial in Los Angeles (arabinoxylan rice bran, Placebo for arabinoxylan rice bran)
Completed
- Inflammation in HIV Infection
- arabinoxylan rice bran
- Placebo for arabinoxylan rice bran
-
Los Angeles, CaliforniaRand Schrader Health and Research Clinic
Apr 27, 2021
Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))
Active, not recruiting
- Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
- Blinatumomab Expanded T-cells (BET)
-
Bergamo, ItalyASST - Papa Giovanni XXIII
Dec 22, 2021
HIV/AIDS Trial in Guangzhou (CAR-T cells)
Recruiting
- HIV/AIDS
- CAR-T cells
-
Guangzhou, Guangdong, ChinaGuangzhou 8th People's Hospital
Jul 19, 2021
SCID Trial in United States (Humanized anti-CD117 Monoclonal Antibody (JSP191))
Recruiting
- SCID
- Humanized anti-CD117 Monoclonal Antibody (JSP191)
-
Los Angeles, California
- +7 more
Nov 16, 2021
Pediatric Patients, Any Type of Severe Combined Immunodeficiency (SCID), Partial HLA Incompatible Allogeneic Hematopoietic Stem
Recruiting
- Pediatric Patients
- +2 more
- Human T Lymphoid Progenitor (HTLP) injection
-
Paris, Ile De France, FranceUnité d'Immunologie Hématologie Rhumatologie Pédiatrique (UIHR),
Apr 13, 2021
Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
-
Birmingham, Alabama
- +38 more
Oct 25, 2021
Recurrent Melanoma, Stage IV Melanoma Trial in Rochester (drug, other, procedure)
Completed
- Recurrent Melanoma
- Stage IV Melanoma
- temozolomide
- +4 more
-
Rochester, MinnesotaMayo Clinic
Sep 28, 2020